Es konnten keine Ergebnisse gefunden werden.
Such-Empfehlungen

Read more
Read less
Registration open!
The program will be updated regularly. Register for the Eppendorf bioprocess spotlight newsletter to stay updated.
Mehr erfahren
Weniger lesen
Monday, November 20, 2023
Mehr erfahren
Weniger lesen
2 pm CET | in-person
Registration
Mehr erfahren
Weniger lesen
3 pm CET | in-person
From cultivation to isolation – Stem cell cultivation in stirred bioreactors and exosome isolation
Pre-conference workshop for (PhD) students, Post Docs and Lab Technicians
Mehr erfahren
Weniger lesen
Tuesday, November 21, 2023
Agenda will be updated frequently
Mehr erfahren
Weniger lesen
8:30 am CET | in-person
registration | welcome coffee
Mehr erfahren
Weniger lesen
9 am - 5:30 pm CET | in-person | online
presentations and poster sessions
Mehr erfahren
Weniger lesen
- Session 1: All about clinical manufacturing
Towards clinical-grade stem cell-derived extracellular vesicles (EV)
Dr. Klaus Graumann, Phonestra GmbH
Efficient and scalable generation of high-quality pluripotent iPSC start material for cell therapy GMP manufacturing in bioreactors
Dr. Felix Manstein, Evotec SE
Towards clinical-grade stem cell-derived extracellular vesicles (EV)
Dr. Klaus Graumann, Phonestra GmbH
Efficient and scalable generation of high-quality pluripotent iPSC start material for cell therapy GMP manufacturing in bioreactors
Dr. Felix Manstein, Evotec SE
coffee break | networking | exhibition
poster pitches
lunch | networking | poster session | exhibition
- Session 2: All about process controll and analytics
Cell-based metabolic profiling assays for cell therapy
Dr. Jolanta Vidugiriene, Promega Corporation
Expansion of hMSC in stirred-tank bioreactors
Dr. Francoise de Longueville, Eppendorf Applications Technologies
Protein-free Differentiation media for hPSC-cardiomyocyte production in up to 2 Liter Stirred-Tank Bioreactors
Nils Kriedemann, PhD Candidate Bioprocess Development
Cell-based metabolic profiling assays for cell therapy
Dr. Jolanta Vidugiriene, Promega Corporation
Expansion of hMSC in stirred-tank bioreactors
Dr. Francoise de Longueville, Eppendorf Applications Technologies
Protein-free Differentiation media for hPSC-cardiomyocyte production in up to 2 Liter Stirred-Tank Bioreactors
Nils Kriedemann, PhD Candidate Bioprocess Development
coffee break | networking | exhibition
- Session 3: All about iPSC
Development of an end-to-end closed iPSC expansion process using a cell specific perfusion regime for process intensification
Patrick Statham, PhD, Catapult
Development of an end-to-end closed iPSC expansion process using a cell specific perfusion regime for process intensification
Patrick Statham, PhD, Catapult
Mehr erfahren
Weniger lesen
5:30 pm CET | in-person
get together with food & drinks
poster prize
Mehr erfahren
Weniger lesen
Register for online or in-person attandance
Mehr erfahren
Weniger lesen
© 2023 Eppendorf SE
Nur für gewerbliche Kunden.